IBO vs REGN: Which Stock is Better?

Side-by-side comparison of Impact Biomedical Inc and Regeneron Pharmaceuticals Inc in 2026

Comparison Updated:

IBO

Impact Biomedical Inc

$0.66

REGN

Regeneron Pharmaceuticals Inc

$746.00

Key Metrics Comparison

MetricIBOREGNWinner
Market Cap$71.50M$79.71BREGN
P/E RatioN/A18.18REGN
EPS (TTM)$N/A$41.47REGN
Revenue Growth0.0%0.0%REGN
Gross Margin-1225.0%44.6%REGN

Analyze IBO

Full quant analysis

Analyze REGN

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is IBO or REGN a better investment?

Comparing IBO and REGN: Impact Biomedical Inc has a market cap of $71.50M while Regeneron Pharmaceuticals Inc has $79.71B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between IBO and REGN?

IBO (Impact Biomedical Inc) and REGN (Regeneron Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: IBO or REGN?

Based on P/E ratios, compare detailed valuation metrics on our dashboard.

Which is growing faster: IBO or REGN?

REGN has higher revenue growth at 0.0% vs 0.0% for IBO.

Which company is more profitable: IBO or REGN?

Regeneron Pharmaceuticals Inc (REGN) has higher gross margins at 44.6% compared to -1225.0% for IBO.

Which is the larger company: IBO or REGN?

Regeneron Pharmaceuticals Inc (REGN) is larger with a market cap of $79.71B compared to $71.50M for IBO.

Should I buy IBO or REGN in 2026?

Both IBO and REGN have investment merit. IBO trades at $0.66 while REGN trades at $746.00. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between IBO and REGN stock?

Key differences: Market Cap ($71.50M vs $79.71B), P/E Ratio (N/A vs 18.2x), Revenue Growth (0.0% vs 0.0%), Gross Margin (-1225.0% vs 44.6%).

Popular Stock Comparisons